Autobio Diagnostics Co (603658.SS) Stock Price
Autobio Diagnostics Co Price
Over the last 14 years Autobio Diagnostics Co grew revenue by 23.8% annually, reaching 4.23 B CNY. Earnings per share have grown at 22.7% per year over the last 14 years. For Autobio Diagnostics Co, the net margin of 25.3% is broadly stable versus 25.9% a few years ago. At today's price the dividend yield works out to roughly 3.25%. The payout ratio is around 67% of earnings. The dividend has grown at 6.2% per year over the past 8 years. The consensus 12-month price target for Autobio Diagnostics Co is 47.45 CNY, about 22.5% above where the stock trades today. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus.
Autobio Diagnostics Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Autobio Diagnostics Co business model & stock analysis
Frequently asked questions about Autobio Diagnostics Co
Analysts currently set an average price target of 44.85 CNY for the Autobio Diagnostics Co stock (median: 47.45 CNY), implying +15.8 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Autobio Diagnostics Co stock: 8 recommend buying, 1 holding and 1 selling. For 2026, analysts expect Autobio Diagnostics Co to generate revenue of 4.43 B CNY and earnings per share of 1.95 CNY.
Converted at the current exchange rate, the Autobio Diagnostics Co share trades at 5.28 EUR (38.72 CNY).
The Autobio Diagnostics Co share (603658.SS) is listed on 1 stock exchanges, including: Shanghai (603658.SS).
The expected revenue of Autobio Diagnostics Co is 4.43 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Autobio Diagnostics Co is 1.11 B CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Autobio Diagnostics Co is currently 19.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Autobio Diagnostics Co stock.
The price-to-sales ratio (P/S) of Autobio Diagnostics Co is currently 4.99. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Autobio Diagnostics Co stock.
The Eulerpool Quality Score for Autobio Diagnostics Co is 5/10.
The ISIN of Autobio Diagnostics Co is CNE100002GC4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Autobio Diagnostics Co is 603658.SS. The ticker symbol is used to trade Autobio Diagnostics Co shares on the stock exchange.
Autobio Diagnostics Co stock
Autobio Diagnostics Co Peer Group
Autobio Diagnostics Co Ticker
Autobio Diagnostics Co FIGI
All fundamentals and in-depth analysis of Autobio Diagnostics Co
Our stock analysis for Autobio Diagnostics Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Autobio Diagnostics Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.